Big Board Impetus

[WI Biker]

PATH $8.73 NuPathe Announces Allowance of U.S. Patent Application for Its Migraine Patch

CONSHOHOCKEN, PA--(Marketwire - 05/02/11) - NuPathe Inc. (NASDAQ:PATH - News), a specialty pharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for U.S. patent application 12/181,142 entitled "Transdermal Methods and Systems for the Delivery of Anti-Migraine Compounds." This application relates to methods of effectively treating a migraine using an iontophoretic patch containing a triptan. Given this action, NuPathe expects the patent to issue within the next few months.

http://finance.yahoo.com/news/NuPathe-Announces-Allowance-iw-232940841.html?x=0&.v=1